Comparison of one-site versus two-site phacotrabeculectomy without the use of antimetabolites intraoperatively in patients with pseudoexfoliation glaucoma and primary open-angle glaucoma

比较单孔与双孔白内障小梁切除术(术中不使用抗代谢药物)治疗假性剥脱性青光眼和原发性开角型青光眼患者的疗效

阅读:2

Abstract

PURPOSE: The comparison of one-site versus two-site phacotrabeculectomy in patients with pseudoexfoliation glaucoma (PEXG) and primary open-angle glaucoma (POAG), with respect to intraocular pressure (IOP), antiglaucomatous medication (AM) requirements and visual acuity (VA). METHODS: Forty-seven patients (eyes) with cataract and POAG and 46 sex- and age-matched patients with cataract and PEXG were randomized to one- or two-site phacotrabeculectomy and reviewed with a follow-up at three years. RESULTS: Mean preoperative IOP was 22.04 +/- 2.27 mmHg and 22.92 +/- 2.35 mmHg in POAG and PEXG groups (p > 0.05) using a mean of 2.76 +/- 0.74, 2.74 +/- 0.69 AM, respectively (p > 0.05). After three years of follow-up, the mean IOP was 15.04 +/- 1.57 mmHg in the one-site, 15.04 +/- 1.99 mmHg in the two-site group with POAG, 15 +/- 1.8 mmHg in the one-site, 15.32 +/- 1.31 mmHg in the two-site group with PEXG, using a mean of 0.68 +/- 0.69, 0.84 +/- 0.75, 0.96 +/- 0.67, and 0.8 +/- 0.62 AM, respectively. Mean IOP and AM postoperatively were significantly less compared to preoperatively for each group (p < 0.05). No difference was observed in mean IOP and AM between the four groups at three years postoperatively (p > 0.05). VA improved similarly in four groups at the three-year follow-up (p < 0.05). Intraoperative, postoperative complications, and need for 5-fluorouracil injections were similar between the surgical groups. CONCLUSION: One-site and two-site phacotrabeculectomy without the use of antimetabolites intraoperatively were similarly safe and effective in IOP control over a three-year follow-up period in patients with POAG and PEXG.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。